Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life during Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Hsu, Pei Yu ^a   Yang, Sien Hung ^a,b   Tsang, Ngan Ming ^a,b   Fan, Kang Hsing ^a   Hsieh, Chia Hsun ^a,b   Lin, Jr Rung ^b   Hong, Ji Hong ^a,c   Lin, Yung Chang ^a,c   Chen, Hsing Yu ^a   Yang, Cheng Tao ^a   Yang, Ching Wei ^a   Chen, Jiun Liang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERVENTION STUDY; MALE; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

EID: 84985909425     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/8359251     Document Type: Article

References (36)

1. S. Warnakulasuriya, "Global epidemiology of oral and oropharyngeal cancer, " Oral Oncology, vol. 45, no. 4-5, pp. 309-316, 2009.
2. S. B. Jensen, A. M. L. Pedersen, A. Vissink et al., "A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life, " Supportive Care in Cancer, vol. 18, no. 8, pp. 1039-1060, 2010.
3. A. Molassiotis, G. Ozden, N. Platin et al., "Complementary and alternativemedicine use in patients with head and neck cancers in Europe, " European Journal of Cancer Care, vol. 15, no. 1, pp. 19-24, 2006.
4. J. D. Schultz, M. Stegmller, A. Faber et al., "Complementary and alternative medications consumed by patients with head and neck carcinoma: A Pilot Study in Germany, " Nutrition and Cancer, vol. 64, no. 3, pp. 377-385, 2012.
5. M. Amin, F. Glynn, S. Rowley et al., "Complementary medicine use in patients with head and neck cancer in Ireland, " European Archives of Oto-Rhino-Laryngology, vol. 267, no. 8, pp. 1291-1297, 2010.
6. I. Kato and A. V. Neale, "Does use of alternative medicine delay treatment of head and neck cancer? A surveillance, epidemiology, and end results (SEER) cancer registry study, " Head & Neck, vol. 30, no. 4, pp. 446-454, 2008.
7. K. Bjordal, A. de Graeff, P. M. Fayers et al., "A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients, " European Journal of Cancer, vol. 36, no. 14, pp. 1796-1807, 2000.
8. N. K. Aaronson, S. Ahinedzai, B. Bergman et al., "TheEuropean Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, " Journal of the National Cancer Institute, vol. 85, no. 5, pp. 365-376, 1993.
9. P. M. Fayers, N. K. Aaronson, K. Bjordal, M. Groenvold, D. Curran, and A. Bottomley, The EORTC QLQ-C30 Scoring Manual, European Organization for Research and Treatment of Cancer, Brussels, Belgium, 3rd edition, 2001.
10. F. Qi, A. Li, Y. Inagaki et al., "Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer, " BioScience Trends, vol. 4, no. 6, pp. 297-307, 2010.
11. J. Dong, S.-Y. Su, M.-Y. Wang, and Z. Zhan, "Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: A Systematic Review, " Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 137, 2010.
12. M.-L. Liu, L.-Y. Chien, C.-J. Tai, K.-C. Lin, and C.-J. Tai, "Effectiveness of traditional Chinese medicine for liver protection and chemotherapy completion among cancer patients, " Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 291843, 8 pages, 2011.
13. W. C. S. Cho and H.-Y. Chen, "Clinical efficacy of traditional Chinesemedicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis, " Cancer Investigation, vol. 27, no. 3, pp. 334-344, 2009.
14. Y.-H. Huang, J.-L. Chen, S.-H. Yang, G.-H. Liu, K.-P. Chang, and N.-M. Tsang, "Influence ofChinesemedicine onweight loss and quality of life during radiotherapy in head and neck cancer, " Integrative CancerTherapies, vol. 12, no. 1, pp. 41-49, 2013.
15. J. Klein, J. Livergant, and J. Ringash, "Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review, " Oral Oncology, vol. 50, no. 4, pp. 254-262, 2014.
16. J. B. Epstein, S. Emerton, D. A. Kolbinson et al., "Quality of life and oral function following radiotherapy for head and neck cancer, " Head & Neck, vol. 21, no. 1, pp. 1-11, 1999.
17. J. O. Deasy, V. Moiseenko, L. Marks, K. S. C. Chao, J. Nam, and A. Eisbruch, "Radiotherapy dose-volume effects on salivary gland function, " International Journal of Radiation Oncology, Biology, Physics, vol. 76, supplement 3, pp. S58-S63, 2010.
18. M. R. Vergeer, P. A. H. Doornaert, D. H. F. Rietveld, C. R. Leemans, B. J. Slotman, and J. A. Langendijk, "Intensitymodulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program, " International Journal of Radiation Oncology Biology Physics, vol. 74, no. 1, pp. 1-8, 2009.
19. A. P. Jellema, B. J. Slotman, P. Doornaert, C. R. Leemans, and J. A. Langendijk, "Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer, " International Journal of Radiation Oncology, Biology, Physics, vol. 69, no. 3, pp. 751-760, 2007.
20. R. Pinna, G. Campus, E. Cumbo, I. Mura, and E. Milia, "Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, andmanagement of the oral damage, " Therapeutics and Clinical RiskManagement, vol. 11, pp. 171-188, 2015.
21. H. Mese and R. Matsuo, "Salivary secretion, taste and hyposalivation, " Journal of Oral Rehabilitation, vol. 34, no. 10, pp. 711-723, 2007.
22. B. A. Murphy and J. Deng, "Advances in supportive care for late effects of head and neck cancer, " Journal of Clinical Oncology, vol. 33, no. 29, pp. 3314-3321, 2015.
23. H. Ganzer, R. Touger-Decker, J. S. Parrott, B. A. Murphy, J. B. Epstein, and M. B. Huhmann, "Symptom burden in head and neck cancer: impact upon oral energy and protein intake, " Supportive Care in Cancer, vol. 21, no. 2, pp. 495-503, 2013.
24. E. Bardet, L. Martin, G. Calais et al., "Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC 2000-02 phase III randomized trial, " Journal of Clinical Oncology, vol. 29, no. 2, pp. 127-133, 2011.
25. C. Q. Cheng, H. Xu, L. Liu et al., "Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: a systematic review and meta-analysis, " Journal of the American Dental Association, vol. 147, no. 4, pp. 236-243, 2016.
26. V. Visvanathan and P. Nix, "Managing the patient presenting with xerostomia: a review, " International Journal of Clinical Practice, vol. 64, no. 3, pp. 404-407, 2010.
27. T. L. Lovelace, N. F. Fox, A. J. Sood, S. A. Nguyen, and T. A. Day, "Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review, " Oral Surgery, OralMedicine, Oral Pathology and Oral Radiology, vol. 117, no. 5, pp. 595-607, 2014.
28. S. Furness, G. Bryan, R. McMillan, S. Birchenough, and H. V. Worthington, "Interventions for themanagement of drymouth: non-pharmacological interventions, " The Cochrane Database of Systematic Reviews, vol. 9, Article IDCD009603, 2013.
29. B. A. Murphy, S. Ridner, N. Wells, and M. Dietrich, "Quality of life research in head and neck cancer: a review of the current state of the science, " Critical Reviews in Oncology/Hematology, vol. 62, no. 3, pp. 251-267, 2007.
30. R. Kohda, T. Otsubo, Y. Kuwakado et al., "Prospective studies on mental status and quality of life in patients with head and neck cancer treated by radiation, " Psycho-Oncology, vol. 14, no. 4, pp. 331-336, 2005.
31. S. A. Duffy, J. E. Terrell, M. Valenstein, D. L. Ronis, L. A. Copeland, and M. Connors, "Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients, " General Hospital Psychiatry, vol. 24, no. 3, pp. 140-147, 2002.
32. L. Licitra, F. Perrone, P. Bossi et al., "High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma, " Journal of Clinical Oncology, vol. 24, no. 36, pp. 5630-5636, 2006.
33. C. Fakhry, W. H. Westra, S. Li et al., "Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, " Journal of the National Cancer Institute, vol. 100, no. 4, pp. 261-269, 2008.
34. L. Masterson, D. M. Winder, S. L. Ball et al., "Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis, " BMC Cancer, vol. 16, article 367, 2016.
35. G. D'Souza, A. R. Kreimer, R. Viscidi et al., "Case-control study of human papillomavirus and oropharyngeal cancer, " The New England Journal of Medicine, vol. 356, no. 19, pp. 1944-1956, 2007.
36. H. Mehanna, T. Beech, T. Nicholson et al., "Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region, " Head & Neck, vol. 35, no. 5, pp. 747-755, 2013.